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Membrane protein structureAnion exchanger 1 (AE1 or band 3) is responsible for Cl−–HCO3− exchange on erythrocyte membrane.
Previously, we showed that band 3 is ﬁxed in an inward-facing conformation by speciﬁc modiﬁcation of His
834 with DEPC, resulting in a strong inhibition of its anion transport activity. To clarify the physiological role
of His 834, we evaluated the sulfate transport activities of various band 3 mutants: different mutants at His
834 and alanine mutants of peripheral residues around 834 (Lys 829–Phe 836) in yeast cell membranes. The
Km values of the His 834 mutants were 4–10 times higher than that of the wild type, while their Vmax values
were barely lower than that of wild type. Meanwhile, the Km values of the peripheral alanine mutants were
only slightly increased. These data suggest that His 834 is critically important for the efﬁcient binding of
sulfate anion, but not for the conformational change induced by substrate binding.,4-diisothiocyanostilbene-2,2-
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Anion transporter band 3 (AE1) exchanges Cl− for HCO3− across
red blood cell membrane [1,2]. Human band 3 is divided into cytosolic
and transmembrane domains. The C-terminal transmembrane do-
main (Gly 361–Val 911), which is thought to penetrate the membrane
12–14 times, has an anion transport function [3]. Many efforts using
site-directed mutagenesis, chemical modiﬁcation, and so on suggest
that some lysine [4–6], arginine [7], glutamic acid [8], and histidine
[9–11] residues of band 3 are essential amino acids for the transport
activity.
The importance of histidine in anion transport has been clariﬁed.
The anion transport rate varied with the intracellular pH. This pH
dependence suggests that intracellularly located histidine participates
in anion transport [9–11]. By introducing a series of mutations at
histidine residues, and Muller-Berger et al. [12] found that four of sixhistidines were involved in Cl− ﬂux through mouse band 3. Chemical
modiﬁcation of band 3 with DEPC, which speciﬁcally reacts with
histidine, leads to the almost complete inhibition of anion transport
and inhibition of Cl− ion binding [10,13]. Mass spectrometric analysis
of tryptic fragments of band 3 revealed that only a single histidine
residue, His 834, was completely modiﬁed with DEPC under the
conditions [9]. His 834 is predicted to exist on the intracellular side of
the membrane. In recent cysteine-scanning works, the anion
transport activity of a cysteine mutant at His 834 was drastically
decreased [14]. Thus, His 834 is critically involved in anion transport.
Anion transport of band 3 was explained by a ping-pong model
[15]. In this model, when a single anion binds to the binding site from
an extracellular side, its outward-facing conformational changes to an
inward-facing conformation and vice-versa. As a result, one molecule
of the substrate anion is transferred across the membrane every time
the conformational changes. These consecutive conformational
changes are evident from the chemical modiﬁcation of band 3.
Stilbene compounds (DNDS, DIDS, and H2DIDS), anion transport
inhibitors, bind to band 3 from an extracellular side. The extracellular
binding of DNDS to band 3, by which the band becomes ﬁxed in the
outward-facing form, hides His 834 from the intracellular side and so
protects His 834 from DEPC modiﬁcation. Conversely, the modiﬁca-
tion of His 834 with DEPC, by which band 3 becomes ﬁxed in the
inward-facing form, hides the extracellular reaction site of H2DIDS
from the cell surface and so abolishes H2DIDS binding. These results
suggest that His 834 changes its location along with the conforma-
tional change during the anion-exchange process. This ﬁnding, in light
of His 834's importance in anion transport, suggests that His 834
contributes to the conformational change. However, there is a
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steric hindrance due to a DEPC adduct.
To rule out this possibility and to clarify the physiological role of
His 834, in the present study we kinetically investigated the sulfate
anion transport activity of mutants at His 834 as well as that of alanine
mutants around His 834. For this purpose, the C-terminal transmem-
brane domain of band 3 was expressed in yeast and integrated into
the plasma membrane. In our yeast system, both Km and Vmax values
well correspond to those measured by using erythrocyte membrane
[7]. Therefore, we consider that our results sufﬁciently reﬂect the
kinetic properties of human band 3 although it is expressed on yeast
membrane. Here we show that His 834 is important for substrate
binding rather than for conformational change.
2. Materials and methods
2.1. Materials
Anti-Vma2p antibody was purchased from Molecular Probes, Inc.
(Eugene, OR). BY4743 was purchased from Invitrogen (Carlsbad, CA).
Other chemical reagents were purchased from Wako Pure Chemical
Industries (Osaka, Japan).
2.2. Expression of band 3 on the yeast plasma membrane
Band 3 expression vector pYES2-FHSHS, which contains GAL1
promoter, and glycophorin A (GPA) co-expression vector pGAD-C1
were prepared as described previously [7]. The mutants of His 834
(H834A, H834E, H834Q, H834R, H834F, and H834I) and peripheral
alanine mutants around His 834 (K829A, T830A, W831A, R832A,
M833A, L835A, and F836A) of residues 361–911 of band 3 were
constructed by established PCR methods [16,17]. Using the pYES2-
FHSHS vector, Flag-tag, His-tag, Strep-tag, His-tag, and Flag-tag se-
quences were added to N-terminuses of their mutants. Mutations were
conﬁrmed by DNA sequence analysis. For anion transport studies, the
pYES2-FHSHS vector harboring each band 3 mutation was transfected
into Saccharomyces cerevisiae strain BY4743 (MATa/α ura3/ura3 leu2/
leu2 his3/his3 lys2/LYS2met15/MET15). To increase the band 3 expres-
sion level on the plasma membrane, vector pGAD-C1, which contains
DNA encoding Δ68–70 GPA, was co-transfected [18]. The transformants
were cultured in leucine/uracil minus medium containing 0.67% yeast
nitrogen base, 1% succinate, 0.6% NaOH, 2% rafﬁnose, and 0.08% amino
acid mix. When the optical density at 600 nm became 0.7, 2% (w/v)
galactosewas added to the culturedmedium to induce the expression of
band 3. The cells were collected at 6 h after the galactose addition.
2.3. Protease accessibility assay
Using a protease accessibility assay, we measured the proportion
of band 3 that transferred to the yeast plasma membrane surface
[7,19]. In brief, we treated the collected cells with 0.1 M Tris–HCl
(pH 8.0) containing 1.2 M sorbitol and 5 mg/ml chymotrypsin at 4 °C
for 1 h. The chymotrypsin-treated cells were washed three times with
0.1 M Tris–HCl (pH 8.0) containing 1.2 M sorbitol and 2 mM
phenylmethanesulfonyl ﬂuoride (PMSF) and were incubated with
1% 2-mercaptoethanol and 240 mM NaOH. The proteins were
precipitated with trichloroacetic acid (TCA) and acetone, and then
were immunoblotted with anti-Flag and anti-Vma2p antibodies. To
investigate chymotrypsin's effect on intracellular protein, we exam-
ined the cleavage of Vma2p. Vma2p is a cytoplasmic protein on the
vacuolar membrane [20]. The gel images were visualized with a
phosphorimager (FLA2000; Fuji, Tokyo, Japan). Quantitation was
performed using MacBAS software (Fuji). The cleavage of the band 3
protein was complete under these conditions because longer
chymotrypsin treatment did not increase the amount of the cleaved
22-kDa fragment (data not shown).2.4. Sulfate transport assay
A sulfate transport assay was carried out as described previously
[7]. In brief, the cell suspension was concentrated by centrifugation
(1000×g, 10 min), and then its OD600 was re-adjusted to 10 in 5 mM
HEPES buffer (pH 6.0) containing 200 mM sucrose, 25 mM gluconate,
25 mM citrate, and 1 mM Na2SO4. To 200 µl samples of the cell
suspension, either 1 µl of water or 1 µl of 2 mM 4,4-diisothiocyana-
tostilbene-2,2-disulfonate (DIDS) (ﬁnal 10 µM) was added to each
tube. There are two endogenous sulfate transporters in S. cerevisiae
[21]. Therefore, we measured 35SO42− incorporation in the presence or
absence of DIDS and calculated the difference for the band-3-speciﬁc
35SO42− incorporation. After pre-incubation for 90 min at 30 °C, the
assaywas started by adding 5 to 160 mMNa2SO4 (ﬁnal concentration)
and 7.5 µCi of 35SO42− (Amersham Biosciences, Piscataway, NJ) to the
cell mixture. After 5 min of incubation at 30 °C at pH 6.0, the cells were
rapidly trapped on a glass ﬁlter and washed three times with 1 ml of
distilled water. The cells were resuspended in Clear-sol I solution
(Nacalai Tesque, Kyoto, Japan), and then radioactivity was measured
by scintillation counting (Liquid Scintillation Counter LSC-5100;
Aloka, Tokyo, Japan). Protease accessibility and sulfate transport
were assayed using cells of the same culture in each independent
experiment.
3. Results
3.1. Expression of various mutants of band 3 on yeast membrane
We expressed the wild type and mutants at His 834 (H834A,
H834E, H834Q, H834R, H834F, and H834I) and alanine mutants
around His 834 (K829A, T830A, W831A, R832A, M833A, L835A, and
F836A) of the band 3 C-terminal domain (residues 361–911) on the
yeast plasma membrane. The yeast expressing wild type as well as
eachmutant protein proliferated to a similar extent (data not shown).
To distinguish the band 3 expressed on the plasma membrane from
that on the endoplasmic reticulum (ER) membrane, we measured the
amount of band 3 on the plasmamembrane by a protease accessibility
assay [19]. Band 3 expressed on the plasma membrane is completely
cleaved by extracellular chymotrypsin between transmembrane
spanning portion (TM) 5 and TM6, which are predicted in a 14-time
membrane spanning model. Thereby, the cleavage of band 3 on the
plasma membrane produces a 22-kDa N-terminal fragment. We
measured the density of the 22-kDa N-terminal fragment bands. It
was also conﬁrmed that intracellular Vma2p was not affected by the
extracellular chymotrypsin treatment (lower panel of Figs. 1A, B). We
estimated that the proportion of band 3 on the plasma membrane in
wild-type cells was about 10%, which was not signiﬁcantly different
between the wild-type cell and all mutant cells (upper panel of
Fig. 1A, B). This indicates that those mutations do not affect band 3
trafﬁcking to the plasma membrane. By comparing the band density
between the band 3 expressed in the yeast and the band 3 puriﬁed
from erythrocyte membrane, the amount of band 3 in the yeast was
calculated. The amount of mutant band 3 expressed on the yeast
membrane was estimated to be about 0.04 mg for the 1 l culture cells.
3.2. Sulfate transport of band 3 mutants
To examine the anion transport activity of band 3 mutants of His
834 on the yeast membrane, we measured 35SO42− incorporation.
Fig. 2A shows the band-3-speciﬁc incorporation of sulfate ion. Using
these data, we plotted the [S/V]–[S] graph as shown in Fig. 2C. The
coefﬁcient of determination (r2) ranged from 0.980 to 0.906,
suggesting that the linearity of the plots was fairly good. S is the
total sulfate concentration. V is the sulfate inﬂux velocity obtained
from the sulfate inﬂux at each sulfate concentration. This inﬂux was
linear for throughout the period of data collection, which was more
Fig. 1. Expression levels of various mutants of band 3. Wild type and various mutants of band 3 were expressed in yeast. The mutants at His 834 and alanine mutants around His 834
are shown in A and B, respectively. Expression levels of band 3 and Vma2p were estimated using Western blotting with anti-Flag and anti-Vma2p antibodies. The ﬁgure shows the
expression of the whole membrane domain of band 3 (odd-numbered lanes) and the production of the N-terminal fragment of the membrane domain after the chymotrypsin
treatment of the wild-type and various mutant cells (even-numbered lanes; see Section 2).
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using the [S/V]–[S] graphs. The level of cell surface expression did not
vary signiﬁcantly between the mutants. Sulfate incorporation was
adjusted by the amount of each mutant in cell surface. Thus, the
difference of Vmax values is due to the intrinsic activity of the
transporter but not to the difference of cell surface expression. In fact,
the calculated values for the wild type andmutants are summarized in
Table 1. The Km (23.7±5.9 mM) and Vmax (5.5±0.6 µmol/min permg
band 3 protein) values of the wild type were essentially the same as
the values previously estimated for band 3 in red blood cells (23 mM
and 5.8 µmol/min per mg band 3 protein [22]). We compared the
kinetic parameters of the mutants. The Vmax values of the His
834 mutants were almost the same as that of the wild type. On the
other hand, the Km values of H834A, H834E, H834Q, H834F, and H834I
markedly increased, to 218.6±49.5, 213.1±69.5, 181.5±47.9,
202.7±36.6, and 233.3±21.4 mM, respectively. The Km values of
H834R moderately increased to 83.9±26.6 mM. These results were
summarized as follows; 1) the Km values of His mutants except H834R
weremarkedly increased, 2) that of H834Rwasmoderately increased,
and 3) Vmax values of all His mutants were not markedly different.
These large increases in Km for the His 834 mutant suggest that His
834 plays a very important role in anion binding.A series of peripheral alanine mutants around His 834 also had
Vmax values similar to that of the wild type (Fig. 2B, 2D, Table 1). The
Km values of K829A, T830A,W831A, R832A,M833A, L835A, and F836A
increased to 44.5±8.5, 38.4±12.9, 41.2±4.7, 32.2±2.0, 63.7±16.9,
27.5±7.4 and 30.9±1.3 mM, respectively. Thus, the increases in Km
of the peripheral mutants were at most moderate compared to those
of the His mutants.
4. Discussion
The signiﬁcance of His 834 was reported by mutation [12,14] and
chemical reagent studies [9,10]. Muller-Berger et al. reported that
H852Q mutation in mouse band 3 (corresponding to His 834 in
human band 3) led to complete inhibition of Cl− transport using a
Xenopus oocyte expression system. Mutation of the DIDS-binding site,
Lys 558 (K558N), restored the transport activity of His 852 mutation.
Therefore, they suggested that Lys 558 and His 852 were allosterically
linked to the transfer site. Furthermore, Zhu et al. examined the effect
of transport activity in the region of Phe806–Cys885 using cysteine
scanning [14]. In their experiment, the transport activity of H834C
mutant was almost completely inhibited. Taken together with our
previous studies, His834 is critical for the anion transport activity.
Fig. 2. Sulfate incorporation in band-3-expressing yeast cells against total sulfate concentration. The cells expressing mutants at His 834 (A) and alanine mutants around His 834 (B)
were pretreated with or without 10 µM DIDS. The cells were incubated in 5 to 160 mM Na2SO4 containing 7.5 µCi of 35SO42− for 5 min at 30 °C, and sulfate incorporation was
measured with a scintillation counter. The difference between the values obtained with and without DIDS was estimated as the band-3-speciﬁc incorporation. The [S/V]–[S] plot
graphs are shown for the cells expressing mutants at His 834 (C) and alanine mutants around His 834 (D). The r2's, which were calculated from the [S/V]–[S] plot, were 0.995–0.906.
In A and C, wild-type-expressing cells, cells transfected with the empty vector, H834A-expressing cells, H834E-expressing cells, H834Q-expressing cells, H834R-expressing cells,
H834F-expressing cells, H834I-expressing cells and wild-type-expressing cells without DIDS are shown by the open circle, cross, open triangle, open square, open diamond,
closed circle, closed triangle, closed square and plus, respectively. In B and D, K829A-expressing cells, T830A-expressing cells, W831A-expressing cells, R832A-expressing cells,
M833A-expressing cells, L835A-expressing cells and F836A-expressing cells are shown by closed square, closed triangle, closed circle, open diamond, open square, open triangle and
open circle, respectively.
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nism largely remain to be solved. For example, (1) what amino acid
properties are important at amino acid position 834?; (2) where is the
most important position around this region?; and (3) which is His 834
more important for, substrate binding or conformational change?
(The location of His 834 and its peripheral residues are shown in
Fig. 3). To answer these questions, in the present study we expressedTable 1
Kinetic parameters of the wild type and various mutants.
Band 3 Km (mM) Vmax (µmol/min/mg) r2
Wild type 23.7±5.9a 5.5±0.6 0.971±0.018
H834A 218.6±49.5** 4.0±0.7 0.953±0.030
H834E 213.1±69.5** 4.5±1.0 0.958±0.033
H834Q 181.5±47.9** 4.6±0.8 0.933±0.058
H834R 83.9±26.6* 4.3±0.7 0.980±0.015
H834F 202.7±36.6** 4.4±1.1 0.939±0.040
H834I 233.3±21.4** 4.3±0.4 0.906±0.030
K829A 44.5±8.5 5.5±0.8 0.984±0.004
T830A 38.4±12.9 5.3±0.7 0.976±0.014
W831A 41.2±4.7 5.0±0.4 0.970±0.005
R832A 32.2±2.0 6.2±0.3 0.967±0.021
M833A 63.7±16.9 4.7±0.7 0.941±0.064
L835A 27.5±7.4 4.9±0.5 0.979±0.018
F836A 30.9±1.3 5.1±0.3 0.995±0.002
a Kinetic parameters of the wild type and various mutants are expressed as
means±S.E. obtained for four or six experiments. r2 is the coefﬁcient of determination.
When compared to value of wild-type, the markedly and moderately changed values
are marked with ** and *, respectively.various mutants of His 834 on yeast membrane and evaluated their
kinetic parameters.
First, to learn what properties of amino acid are important at this
position, we prepared hydrophobic (H834I and H834F), acidic
(H834E) and basic (H834R) mutants. The Km values of all of these
mutants except H834R were increased by about 8- to 10-fold
(Table 1). H834R increased the Km by only 4-fold, suggesting that
the positive charge of arginine partially compensates for that of
histidine. Previous studies suggest that the protonation of the
histidine residue is involved in the anion transport. For instance, the
phosphoenolpyruvate transport rate increased under acidic condi-
tions [11]. Therefore, we expect that the positive charge at position
834 is important for anion binding. Band 3 transports anions by the
ping-pong mechanism. The bound anion in the intracellular side has
to be released to the extracellular side according to the conforma-
tional change. Therefore, tight anion binding due to the electrostatic
interaction may rather interrupt the anion release. Therefore, His, a
weaker base than Arg, may be suitable for the anion transport or for
the anion binding and release under physiological condition. In
addition to its weak basic nature, the structure of histidine itself could
be important.
Next, to evaluate the importance of the position, we measured the
kinetic parameters of alanine mutants of peripheral residues of His
834 (Lys 829–Phe 836). The increases in the Km values of these
mutants were at most moderate (1.7- to 2.7-fold) compared to those
of all the His 834 mutants, including H834A, suggesting that position
834 is most important in this region (Lys 829–Phe 836). For further
conﬁrmation, histidine can replace the peripheral amino acids of Lys
Fig. 3. Topology model of the transmembrane domain of band 3. The residues of Lys 829–Phe 836 are shown by closed black circles. His 834 is indicated by an arrow.
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and Phe836) differed between our and Zhu's studies. However, we
used alanine mutants, and they used cysteine mutants. Therefore,
these residues are thought as sensitive residues in transport activity.
One possibility is that the SH group may interact with another residue
and induce conformational change around His834.
Finally we consider the role of His 834 in the conformational
change. We previously showed that modiﬁcation with DEPC at His
834 ﬁxed band 3 in the inward-facing conformation and inhibits anion
transport completely [9]. We therefore have proposed that His 834
has an essential role in the conformational change between inward-
and outward-facing conformations. However, chemical modiﬁcation
with DEPC produces a mono-carbetoxy group adduct on histidine. It
may be possible that the freezing of the conformation by the DEPC
modiﬁcation of His 834 results simply from steric hindrance caused by
the DEPC adduct. To avoid this possibility, we produced the His 834
mutants. Based on the ping-pong model, Vmax should reﬂect
conformational change and Km should reﬂect the anion binding. In
the present study, we demonstrated for the ﬁrst time that the Vmax
values of the His 834mutants were only slightly decreased (16%–24%)
while the Km increased markedly. Based on the ping-pong model,
anion transport is performed through the conformational change. The
rate of anion transport depends on the rate of conformational change.
Therefore, this small decrease in Vmax suggests that His 834 may
hardly contribute to the conformational change. Thus, the unaltered
Vmax and increased Km values of the His mutants strongly suggest that
His834 is important for the anion binding. Our ﬁnding about His 834
may support the previous results that the mutation of the DIDS
reactive lysine residue did not inhibit transport, but chemical
modiﬁcation did [6,23].
The expression of the C-terminal domain of band 3 on the yeast
membrane allows us to evaluate not only the Km but also the Vmax (or
speciﬁc activity). These two parameters are fundamental features ofenzymes. In this study, we performed for the ﬁrst time an intensive
kinetic analysis of the His 834 mutants by taking advantage of this
expression system. Here, we have revealed that the primary role of
His 834 is in anion binding and not in conformational change.
Hereafter, this expression system will be an important tool for further
molecular and functional analyses of band 3.Acknowledgements
This work was supported in part by Grants-in-Aid for Scientiﬁc
Research from the Ministry of Education, Culture, Sports, Science and
Technology of Japan to Y. A. and N. H. We also thank KN-international
for improving our English of our manuscript.References
[1] N. Hamasaki, M. Yamamoto, Red blood cell function and blood storage, Vox Sang.
79 (2000) 191–197.
[2] N. Hamasaki, K. Okubo, Band 3 protein: physiology, function and structure, Cell
Mol. Biol. (Noisy-le-grand) 42 (1996) 1025–1039.
[3] S.E. Lux, K.M. John, R.R. Kopito, H.F. Lodish, Cloning and characterization of band 3,
the human erythrocyte anion-exchange protein (AE1), Proc. Natl. Acad. Sci. U.S.A.
86 (1989) 9089–9093.
[4] C.E. Cobb, A.H. Beth, Identiﬁcation of the eosinyl-5-maleimide reaction site on the
human erythrocyte anion-exchange protein: overlap with the reaction sites of
other chemical probes, Biochemistry 29 (1990) 8283–8290.
[5] Y. Abe, T. Chaen, X.R. Jin, T. Hamasaki, N. Hamasaki, Mass spectrometric analyses
of transmembrane proteins in human erythrocyte membrane, J. Biochem. (Tokyo)
136 (2004) 97–106.
[6] K. Okubo, D. Kang, N. Hamasaki, M.L. Jennings, Red blood cell band 3. Lysine 539 and
lysine 851 react with the same H2DIDS (4, 4′-diisothiocyanodihydrostilbene-2,
2′-disulfonic acid) molecule, J. Biol. Chem. 269 (1994) 1918–1926.
[7] S. Takazaki, Y. Abe, D. Kang, C. Li, X. Jin, T. Ueda, N. Hamasaki, The functional role of
arginine 901 at the C-terminus of the human anion transporter band 3 protein,
J. Biochem. (Tokyo) 139 (2006) 903–912.
[8] M.L. Jennings, J.S. Smith, Anion–proton cotransport through the human red blood
cell band 3 protein. Role of glutamate 681, J. Biol. Chem. 267 (1992) 13964–13971.
908 S. Takazaki et al. / Biochimica et Biophysica Acta 1798 (2010) 903–908[9] X.R. Jin, Y. Abe, C.Y. Li, N. Hamasaki, Histidine-834 of human erythrocyte band 3
has an essential role in the conformational changes that occur during the band
3-mediated anion exchange, Biochemistry 42 (2003) 12927–12932.
[10] K. Izuhara, K. Okubo, N. Hamasaki, Conformational change of band 3 protein
induced by diethyl pyrocarbonate modiﬁcation in human erythrocyte ghosts,
Biochemistry 28 (1989) 4725–4728.
[11] H. Matsuyama, Y. Kawano, N. Hamasaki, Involvement of a histidine residue in
inorganic phosphate and phosphoenolpyruvate transport across the human
erythrocyte membrane, J. Biochem. (Tokyo) 99 (1986) 495–501.
[12] S. Muller-Berger, D. Karbach, J. Konig, S. Lepke, P.G. Wood, H. Appelhans, H.
Passow, Inhibition of mouse erythroid band 3-mediated chloride transport by
site-directed mutagenesis of histidine residues and its reversal by second site
mutation of Lys 558, the locus of covalent H2DIDS binding, Biochemistry 34
(1995) 9315–9324.
[13] N. Hamasaki, K. Izuhara, K. Okubo, Y. Kanazawa, A. Omachi, R.A. Kleps, Inhibition
of chloride binding to the anion transport site by diethylpyrocarbonate
modiﬁcation of Band 3, J. Membr. Biol. 116 (1990) 87–91.
[14] Q. Zhu, D.W. Lee, J.R. Casey, Novel topology in C-terminal region of the human
plasma membrane anion exchanger, AE1, J. Biol. Chem. 278 (2003) 3112–3120.
[15] W. Furuya, T. Tarshis, F.Y. Law, P.A. Knauf, Transmembrane effects of intracellular
chloride on the inhibitory potency of extracellular H2DIDS. Evidence for two
conformations of the transport site of the human erythrocyte anion exchange
protein, J. Gen. Physiol. 83 (1984) 657–681.[16] R.K. Saiki, D.H. Gelfand, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. Mullis, H.A.
Erlich, Primer-directed enzymatic ampliﬁcation of DNA with a thermostable DNA
polymerase, Science 239 (1988) 487–491.
[17] G. Sarkar, S.S. Sommer, The “megaprimer” method of site-directed mutagenesis,
Biotechniques 8 (1990) 404–407.
[18] M.T. Young, M.J. Tanner, Distinct regions of human glycophorin A enhance human
red cell anion exchanger (band 3; AE1) transport function and surface trafﬁcking,
J. Biol. Chem. 278 (2003) 32954–32961.
[19] J.D. Groves, M.J. Tanner, Co-expressed complementary fragments of the human
red cell anion exchanger (band 3, AE1) generate stilbene disulfonate-sensitive
anion transport, J. Biol. Chem. 270 (1995) 9097–9105.
[20] R.D. Doherty, P.M. Kane, Partial assembly of the yeast vacuolar H(+)-ATPase in
mutants lacking one subunit of the enzyme, J. Biol. Chem. 268 (1993) 16845–16851.
[21] H. Cherest, J.C. Davidian, D. Thomas, V. Benes, W. Ansorge, Y. Surdin-Kerjan,
Molecular characterization of two high afﬁnity sulfate transporters in Saccharomyces
cerevisiae, Genetics 145 (1997) 627–635.
[22] L.J. Bruce, J.D. Groves, Y. Okubo, B. Thilaganathan, M.J. Tanner, Altered band 3
structure and function in glycophorin A- and B-deﬁcient (MkMk) red blood cells,
Blood 84 (1994) 916–922.
[23] P.G.Wood, H. Muller, M. Sovak, H. Passow, Role of Lys 558 and Lys 869 in substrate
and inhibitor binding to the murine band 3 protein: a study of the effects of site-
directed mutagenesis of the band 3 protein expressed in the oocytes of Xenopus
laevis, J. Membr. Biol. 127 (1992) 139–148.
